EFSA 2 mg CBD daily limit (Europe): What It Means for Consumers, Industry, and Research
EFSA 2 mg CBD daily limit (Europe) has reset expectations for CBD safety across the European Union. Because regulators aim to protect consumers, this provisional cap matters for users and companies. If you make, sell, study, or use CBD products, this decision could change your plans.
This introduction explains why the limit emerged and why it matters for research. First, we outline how EFSA arrived at 2 milligrams per day. We explain the related benchmark of 0.0275 milligrams per kilogram for a 70 kilogram adult. We also summarize who falls outside the guidance, including pregnant people and adults under 25.
Finally, we preview the article structure. You will find sections on toxicology, novel food applications, industry responses, and remaining data gaps. Therefore, you will get clear takeaways for safety, compliance, and future studies.
Related keywords include CBD, 2 milligrams per day, novel food, toxicological data, liver effects, and chronic exposure.
EFSA 2 mg CBD daily limit (Europe): What it is and why it matters
The EFSA 2 mg CBD daily limit (Europe) is a provisional safe intake set by the European Food Safety Authority. EFSA derived a provisional benchmark of 0.0275 milligrams per kilogram of body weight. For a 70 kilogram adult, that equals roughly 2 milligrams per day. Because the limit responds to uncertainty over long term effects, EFSA added conservative safety factors.
Regulatory background and EFSA’s role
EFSA evaluates novel foods and chemical safety across the EU. Therefore, it reviewed toxicology and human data for cannabidiol and concluded the provisional level. EFSA paused evaluations in June 2022 because of data gaps, and later resumed work as new studies arrived. The panel excluded people under 25, pregnant or breastfeeding people, and those on medication from the safe intake recommendation.
Practical implications for consumers and businesses
Key points to know
- Consumers: check product labels, because many items contain more than 2 milligrams per serving. However, vulnerable groups should avoid CBD unless advised by a clinician.
- Businesses: product formulations and novel food applications must now meet EFSA’s conservative benchmark or supply stronger safety data.
- Regulators: EFSA is reviewing roughly 200 novel food applications for CBD across the EU.
For context, the United Kingdom advises a 10 milligram daily cap for foods and supplements, while industry groups like the European Industrial Hemp Association have pushed for higher levels. For EFSA’s original statement see here. For the UK guidance see here. For industry reaction read here.
Practical implications for consumers: EFSA 2 mg CBD daily limit (Europe)
The EFSA 2 mg CBD daily limit (Europe) changes how many people should use oral cannabidiol products. Because EFSA set a provisional cap, consumers should reassess typical doses. Many oils, capsules, and foods contain more than two milligrams per serving.
Dosage guidance and common products
EFSA used a benchmark of 0.0275 milligrams per kilogram, so a 70 kilogram adult equals about two milligrams per day. However, common products often deliver tens of milligrams per dose. Therefore, consumers must check label amounts and serving sizes. If a product lists CBD per bottle only, calculate CBD per serving before use.
Safety concerns to know
EFSA highlighted gaps in long term data and possible liver effects, neurological impacts, and reproductive system risks. Consequently, it excluded people under 25, pregnant or breastfeeding people, and those on medication from the recommendation. If you take prescription drugs, consult a clinician before starting CBD.
Product labeling and quality
Read labels for total CBD per serving, source of CBD, and third party testing. Use products with certificates of analysis from accredited labs. As a result, you reduce the risk of inaccurate dosing and unexpected contaminants.
Tips for consumers
- Start with the lowest effective dose, because small changes change your total daily intake
- Check how many milligrams appear per serving and per package
- Divide total milligrams by servings to track daily intake accurately
- Consult a health professional if you take medicines or have health conditions
- Favor products with third party lab results and clear batch information
- Pause use if you notice unusual liver symptoms and seek medical advice
Stay informed
Follow EFSA for updates at EFSA news. Also review national guidance such as Food Standards Agency advice. For broader regulatory context see Health Canada at Health Canada.
Comparing EFSA 2 mg CBD daily limit (Europe) with other regions
| Region | Daily limit or regulatory stance | Practical note and source |
|---|---|---|
| European Union (EFSA) | Provisional safe intake about 2 mg per day (0.0275 mg/kg for 70 kg adult) | Conservative benchmark; excludes those under 25, pregnant, breastfeeding, or on medication. Source: EFSA |
| United Kingdom | Precautionary cap 10 mg per day for foods and supplements (FSA guidance) | National advisory level; affects product labels and marketing. Source: FSA |
| Canada | No fixed legal daily limit; advisory data show tolerability 20–200 mg short term | Health Canada treats CBD as regulatorily sensitive. Source: Health Canada |
| United States | No federal approval for CBD in foods or supplements; FDA approves one drug | FDA enforces restrictions and issues warnings to illegal sellers. Source: FDA |
| Switzerland | Federal authorities treat CBD as a novel food; no single numeric federal limit | A 12 mg per day benchmark is often cited in sector discussion; check federal guidance. Source: BLV |
Conclusion
The EFSA 2 mg CBD daily limit (Europe) marks a cautious turning point for cannabidiol regulation. Because EFSA used conservative safety factors, the provisional cap affects labels, formulations, and consumer expectations. For consumers, the guidance means closer attention to dosing and vulnerable-group exclusions.
For industry, the limit raises compliance and product-development challenges. Manufacturers must now justify higher doses with solid toxicology and human-data. Therefore, companies pursuing novel food approvals should invest in rigorous studies and clear documentation.
Unresolved science remains, however, and regulators may revise the benchmark as data improve. As a result, both consumers and businesses should track updates and national guidance. Check product labels, review third party lab reports, and consult healthcare professionals when mixing CBD with medicines.
MyCBDAdvisor is a U.S. blog committed to clear, reliable CBD, hemp, and cannabinoid information. We emphasize accuracy, simplicity, and transparency. Visit our site to learn more and follow our coverage of evolving rules and research: MyCBDAdvisor.
Frequently Asked Questions (FAQs)
What is the EFSA 2 mg CBD daily limit?
The EFSA 2 mg CBD daily limit is a provisional safe intake set by the European Food Safety Authority. It corresponds to about 0.0275 milligrams per kilogram of body weight, which equals roughly 2 milligrams for a 70 kilogram adult. EFSA applied conservative safety factors because long term data remain limited.
Who is excluded from this guidance?
EFSA excludes people under 25, pregnant or breastfeeding people, and those on medication. Therefore, these groups should avoid CBD unless a clinician advises otherwise.
Should I stop using CBD products?
Not necessarily. However, check product labels and calculate your total daily CBD. If your intake exceeds 2 milligrams per day, reduce the dose or consult a healthcare professional.
How do I calculate daily CBD intake?
Divide total CBD in the container by servings per container to find milligrams per serving. Then multiply by servings you use. Track totals across products to stay below EFSA’s benchmark.
Where can I find authoritative updates?
Monitor EFSA’s official page and national food agencies. Also review peer reviewed studies and third party lab reports for evolving evidence. Check updates regularly.
